logo
On a trade deadline day that called for action, the Cubs hugged their prospects tight

On a trade deadline day that called for action, the Cubs hugged their prospects tight

New York Times4 days ago
CHICAGO — If you were looking for a blockbuster trade deadline, you came to the wrong city.
Try San Diego or Houston.
On Thursday, the Cubs played it safe, while the White Sox tried to muster some enthusiasm about another season of Luis Robert Jr. Meanwhile, Chicago just collectively shook its head and asked when the Bears' first preseason game is.
Advertisement
All that time spent coming up with fake trades was wasted.
It's fair to say the best addition by either team at the deadline was when Cubs president of baseball operations Jed Hoyer swung a deal for 'super-utilityman' Willi Castro.
The White Sox, who have used a hot streak to vault from the second-worst record in baseball to the second-worst record in baseball, made just two deals in the last two days.
The Cubs made a handful of moves but didn't address their most obvious need: starting pitching.
Sox general manager Chris Getz's only real trade chip was rental starting pitcher Adrian Houser. While he apparently had conversations with his friend Hoyer about another crosstown deal, it didn't happen.
The Cubs and Sox almost had a trade for Adrian Hauser. ' We worked really hard but didn't quite get there.'Hoyer told me. Getz confirmed that they had conversations up to 30 min before the deadline.Getz said he thought they were close for the prospects they asked for.
— Bruce Levine (@MLBBruceLevine) August 1, 2025
Once I saw that Getz traded Houser to the savvy Tampa Bay Rays, I figured he probably lost the deal.
In return for Houser, Getz got a former top prospect in Curtis Mead and two Triple-A relievers. The Charlotte Knights improved with this deal, but I'm not so sure about the White Sox. The easy comparison, and one Getz himself made, was to his deadline deal last year when he picked up Miguel Vargas from the Los Angeles Dodgers.
Vargas looked like he had never previously hit a baseball last season. This season, he is only slightly below average offensively, which is a massive improvement. Another year, another project. (Getz also got a minor-league pitcher from the Yankees for outfielder Austin Slater.)
The big news on Thursday was that Getz couldn't swing a trade of Robert, his former All-Star. It wasn't that big of a surprise considering how Robert has played for most of the season. Though he has heated up lately, no smart GM would trade top prospects for such an unsure thing. Unfortunately for Getz, most of the dumb ones aren't running teams in playoff contention.
Advertisement
In the wake of this failure, Getz tried to express his utmost faith in Robert, who has been unreliable and unproductive for the past two seasons.
'It starts with Luis and how we feel about him,' he said. 'You look at what he's done in the last month or so and he's impacting the game in so many different ways, which speaks to the talent he has. We believe in Luis Robert.'
We believe in Luis Robert … until next season, when we try desperately to trade him again. First, they have to pick up his $20 million option, which might give Jerry Reinsdorf some agita, but it's a bet they have to make.
OK, that's enough White Sox.
The Cubs were the team with the most to gain this week and their results are mixed at best. At worst, this was a failure. If we can meet in the middle, it was a missed opportunity.
Hoyer got swingman Michael Soroka on Wednesday and added relievers Andrew Kittredge and Taylor Rogers on Thursday. And if they weren't going to swing for the fences with Eugenio Suárez, Castro was a perfect addition for their needs. He can play multiple positions in the infield and outfield. He's the kind of guy that playoff teams get at the deadline.
As for the pitchers, well, we'll see. Relievers are a volatile bunch. I trust the Cubs' pitching department, but none of these guys are Mason Miller or Jhoan Duran. And aside from Soroka, who will probably be slotted into the bullpen down the stretch, they aren't starters.
Early Thursday evening, Hoyer walked into a second-floor conference room where the media was holed up to address his trade deadline moves and lack thereof. He wasn't thrilled to see a news conference setup. If he landed a top starter, he would've done cartwheels to the backdrop and lectern.
Instead, Hoyer had to address his missed opportunity to find a starter for a beleaguered rotation. Sure, Jameson Taillon and Javier Assad could be close to returning from their injury rehabs. But this is a team that desperately needed a proven starter not only for October, but also to help hold off the Brewers, who are currently in first place in the NL Central.
'The goal is to be good every year … the goal is not to have massive up-and-down cycles.' – Jed Hoyer pic.twitter.com/aznUyi6A6Q
— Marquee Sports Network (@WatchMarquee) August 1, 2025
Like a lot of baseball execs did Thursday, Hoyer noted the bold-faced names, the starting pitchers with years of control left, weren't traded at all. The teams that kept them wanted the farm in return, so to speak, and Hoyer drew a line in the dirt.
'I think that we obviously worked hard on some guys that I feel like could provide significant impact,' he said. 'In the end, the asking price on those guys would have been so detrimental to our future that we've obviously decided against it.'
Advertisement
You might call it prospect-hugging, Hoyer calls it responsible stewardship for a franchise he'll be running for the foreseeable future. His contract extension was announced Monday. All that talk about timing to help him at the trade deadline was just more wasted breath.
Going into a lame-duck season, Hoyer made a win-now move in the winter when he traded his 2024 top pick, Cam Smith, to Houston for one year of Kyle Tucker. On one hand, it has worked out for both teams. Smith went from prospect to starter for the Astros, and Tucker was looking like an MVP until the last month. But if the Cubs don't do anything this postseason and Tucker walks, it will no longer be looked at as such a win-win deal.
That's why the conventional wisdom was that Hoyer would take a couple more big swings at the deadline to try to improve his odds.
Now, if Hoyer had to deal multiple top prospects for starters with years of control, and if teams were really asking for Matt Shaw and Cade Horton, you can see why that's a nonstarter for him.
'Whether it's in this offseason or in the past, I think, certainly we've moved top prospects, but the calculus that we have to make is ultimately what is the impact this is making and how many wins are we losing going forward,' he said.
But all logic that doesn't make the Cubs' situation any more enviable now or in the future. The Cubs are going to need some luck to make a run in the postseason, and they'll still need to spend money — not chairman Tom Ricketts' favorite thing to do — in the offseason to keep this train moving.
It all comes back to money. If the Cubs had paid up for Alex Bregman in the offseason or spent more money on pitching — aside from Matthew Boyd's bargain of a deal — then Hoyer wouldn't be in the position to worry about the price of deadline poker.
Advertisement
But that's not the Cubs' reality, and Hoyer is left trying to toe the line between the present and the future.
'I think the job is to make the best decisions for the organization,' he said. 'And there's times that's focused on just right now and there's times that's focused on the future. And those are the conversations we have every day. So we try to be as unemotional about those as possible.'
In related news, the Cubs DFA'd former closer Ryan Pressly to make room for Rogers, the aforementioned reliever acquired from the Pirates. In his last outing in Milwaukee on Tuesday, Pressly gave up a grand slam to Andrew Vaughn to break open a close game.
Pressly was one of Hoyer's big acquisitions this offseason, but he didn't pitch up to his reputation and lost his job to Daniel Palencia. Now he's looking for a new place to pitch.
Can Rogers and Kittredge help the bullpen survive? Can those two, along with Soroka, be the kinds of 'out-getters' that manager Craig Counsell needs?
Will any of the prospects they didn't trade, like Owen Caissie, Kevin Alcantara and Moisés Ballesteros, be the reinforcements the team needs down the stretch?
On a day when the Cubs were supposed to get some answers, a lot of questions remain.
The most important one — 'Did the Cubs do enough?' — will be answered over the next two to three months.
(Photo of Kyle Tucker: Benny Sieu / Imagn Images)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NFL Top 100: Buccaneers QB Baker Mayfield is No. 50, will play the Cardinals in 2025
NFL Top 100: Buccaneers QB Baker Mayfield is No. 50, will play the Cardinals in 2025

Yahoo

time6 minutes ago

  • Yahoo

NFL Top 100: Buccaneers QB Baker Mayfield is No. 50, will play the Cardinals in 2025

This week, the NFL began its sixth week revealing players in the "NFL Top 100." This week, players 41-50 will be revealed. On Monday, a player the Arizona Cardinals will face in the back half of this coming season came in at No. 50. Player No. 50 is Tampa Bay Buccaneers quarterback Baker Mayfield. He was not in the top 100 in 2024. Mayfield led the Bucs to the playoffs for the second straight year, winning the NFC South, giving the Bucs five straight playoff appearances. He had his best season in 2024, completing 71.4% of his passes for 4,500 yards, 41 touchdowns and 16 interceptions. He was third in the NFL in passing yards, third in completion percentage and second in touchdown passes. He also led the NFL in interceptions. "The ultimate teammate," said running back Rachaad White, Mayfield's teammate. Houston Texans running back Joe Mixon, No. 58 in the top 100, said Mayfield "wakes up, like he says, feeling dangerous." He is the closest thing to Brett Favre this generation has seen. He is a gamer, an incredible competitor. He "can make some crazy plays," according to 49ers quarterback Brock Purdy. Saints safety J.T. Gray said Mayfield has "a Superman ability." However, he has never beaten the Cardinals. He is 0-3 against the Cardinals and Kyler Murray, his old buddy at Oklahoma. The Cardinals have a six-game stretch to end the 2025 regular season with four games against 2024 division winners and two teams that just missed the playoffs last season. That stretch opens in Week 13 with the Bucs on the road. Can Murray and the Cardinals keep Mayfield winless against them one more time? We will see. 'NFL Top 100' opponents for Cardinals in 2025 Of the players in the top 100 revealed as of this week, the Cardinals face the following: QB Baker Mayfield, Tampa Bay Buccaneers (No. 50) OLB Jared Verse, LA Rams (No. 53) DE Nick Bosa, San Francisco 49ers (No. 57) RB Joe Mixon, Houston Texans (No. 58) QB Matthew Stafford, LA Rams (No. 59) RB Bijan Robinson, Atlanta Falcons (No. 62) DE Josh Hines-Allen, Jacksonville Jaguars (No. 63) QB Jordan Love, Green Bay Packers (No. 68) QB Sam Darnold, Seattle Seahawks (No. 72) RB Christian McCaffrey, San Francisco 49ers (No. 73) DT Vita Vea, Tampa Bay Buccaneers (No. 75) WR Tee Higgins, Cincinnati Bengals (No. 77) QB Dak Prescott, Dallas Cowboys (No. 79) DE Rashan Gary, Green Bay Packers (No. 80) RB Kyren Williams, LA Rams (No. 85) S Jessie Bates III, Atlanta Falcons (No. 92) LB Lavonte David, Tampa Bay Buccaneers (No. 96) WR Drake London, Atlanta Falcons (No. 97) DL Leonard Williams, Seattle Seahawks (No. 99) Get more Cardinals and NFL coverage from Cards Wire's Jess Root and others by listening to the latest on the Rise Up, See Red podcast. Subscribe on Spotify, YouTube or Apple podcasts. This article originally appeared on Cards Wire: Arizona Cardinals to face No. 50 in 'NFL Top 100' in 2025

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Yahoo

time6 minutes ago

  • Yahoo

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Paracetamol Market size & share revenue was valued at approximately USD 876.48 Million in 2024 and is expected to reach USD 922.41 Million in 2025 and is expected to reach around USD 1460.23 Million by 2034, at a CAGR of 5.24% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Aspen Pharmacare, Adcock Ingram, Julphar (Gulf Pharmaceutical Industries), Ache Laboratories Pharmaceutics, EMS Pharma, Hikma Pharmaceuticals, Bharat Chemicals, Farmson Pharmaceuticals, SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation), Mylan N.V. (now part of Viatris) and others. Austin, TX, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Paracetamol Market Size, Trends and Insights By Product Type (Tablet, Capsule, Liquid Suspension, Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application Type (Headache & Fever, Muscle Cramps, Cold & Cough), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of the global Paracetamol Market size & share was valued at approximately USD 876.48 Million in 2024 and is expected to reach USD 922.41 Million in 2025 and is expected to reach a value of around USD 1460.23 Million by 2034, at a compound annual growth rate (CAGR) of about 5.24% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Paracetamol Market @ Overview As per the industry experts at CMI, the paracetamol market is expected to witness a linear CAGR during the forecast period. This could be attributed to steadiness on the part of demand for paracetamol globally. Paracetamol is being used as an antipyretic and analgesic, especially in fever and pain relief medications. The market is further catalyzed by growing healthcare awareness, increasing incidences of chronic conditions, and a rising aging population worldwide. Key Trends & Drivers Growing Incidences of Fever and Pain to Determine Growth: Ailments such as flu, headaches, arthritis, and post-operative pain are reported to be managed using paracetamol. Rising incidences on their part do directly translate into a higher demand for medication. The consumers are also increasingly developing awareness about OTC medications such as paracetamol and do prefer treating minor illnesses on their own, thereby driving its usage further. Request a Customized Copy of the Paracetamol Market Report @ Increased Usage in Surgical Applications to Catalyze the Paracetamol Market: IV paracetamol is increasingly preferred due to its ability to effectively manage moderate to severe pain without side effects linked with opioids, such as constipation and nausea. It makes provision for quicker pain relief in comparison with oral medications, thereby making it the most sought-after medication post-surgery. Report Scope Feature of the Report Details Market Size in 2025 USD 922.41 Million Projected Market Size in 2034 USD 1460.23 Million Market Size in 2024 USD 876.48 Million CAGR Growth Rate 5.24% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product Type, Distribution Channel, Application Type and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Paracetamol report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Paracetamol report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Paracetamol Market Report @ SWOT Analysis Strengths: Paracetamol is easily accessible OTC in various forms such as capsules, tablets, and liquids. It is comparatively inexpensive, thereby rendering it cost-effective for a wider consumer base. Plus, it is one of the common ingredients in various fever-reducing and pain relief products and is used for treating conditions such as muscle aches, headaches, and the common cold. Rising occurrences of lifestyle-oriented ailments are the catalysts to paracetamol market. Weaknesses: Improper dosage or overuse could cause damage to the liver. Additionally, the reliance of the market on API production in certain regions is likely to create vulnerabilities pertaining to the supply chain. Furthermore, the market is bound to face fierce competition from the manufacturers of generic medicines, which could reduce the market share of established players and reduce their overall profitability. Opportunities: Researching and developing paracetamol-based products for specified pain conditions such as migraines are likely to unlock novel market segments. Also, exploration of the use of paracetamol in conjunction with the other drugs for improved pain relief and the other therapeutic advantages could provide lucrative opportunities to the paracetamol market. Threats: Negative publicity around the safety concerns related to paracetamol is likely to negatively affect the consumers' demand and perception. Also, Volatility of costs of raw materials used in the production of paracetamol could adversely affect profitability and production costs. Emergence of newer combinations of pain management solutions could also cut down on market share. Request a Customized Copy of the Paracetamol Market Report @ Key questions answered in this report: What is the size of the Paracetamol market and what is its expected growth rate? What are the primary driving factors that push the Paracetamol market forward? What are the Paracetamol Industry's top companies? What are the different categories that the Paracetamol Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Paracetamol market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Paracetamol Research Report | Fast Delivery Available - [220+ Pages] @ Regional Perspective The paracetamol market is divided into North America, Europe, Asia Pacific, and LAMEA. North America North America leads the paracetamol market, and the status quo is expected to remain unchanged during the forecast period. This is credited to rising incidences of migraines, headaches, and fever all across the U.S. The American Migraine Foundation states that the year 2020 witnessed the presence of over 4 million adults in the U.S. battling chronic daily migraine, that too, with close to 15 headaches per month. The government is also handsomely investing in research regarding therapeutics for chronic pain. As per the May 2022 update from the NIH (National Institute of Health), the government of the U.S. did spend USD 689 Million and USD 725 Million in 2020 and 2021 respectively in this regard. Europe Europe is expected to hold a significant share of the paracetamol market owing to an increase in healthcare spending on the part of the governments. The tropical regions are prone to year-round influenza, which is fueling the market therein. The EU has set stringent regulatory standards for various pharmaceuticals (inclusive of paracetamol), which ascertain safety and quality. Asia Pacific Asia Pacific is expected to witness the highest CAGR in the paracetamol market during the forecast period. This could be due to a rise in the population suffering from the common cold, cough, fever, and migraine. China and India are the major manufacturers of paracetamol APIs. They are thus paving the way for cost-effective supply chains. LAMEA Individuals in LAMEA are gaining more awareness regarding the advantages of self-treating the minor ailments with OTC medications such as paracetamol, thereby resulting in a higher rate of consumption. Increase in accessibility of e-Commerce platforms and online pharmacies is making it simpler for the consumers based in LAMEA to buy paracetamol, thereby boosting the market further. Request a Customized Copy of the Paracetamol Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'Paracetamol Market Size, Trends and Insights By Product Type (Tablet, Capsule, Liquid Suspension, Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application Type (Headache & Fever, Muscle Cramps, Cold & Cough), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at List of the prominent players in the Paracetamol Market: Johnson & Johnson GlaxoSmithKline Pfizer Inc. Novartis AG Reddy's Laboratories Ltd. Aspen Pharmacare Adcock Ingram Julphar (Gulf Pharmaceutical Industries) Ache Laboratories Pharmaceutics EMS Pharma Hikma Pharmaceuticals Bharat Chemicals Farmson Pharmaceuticals SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation) Mylan N.V. (now part of Viatris) Others Click Here to Access a Free Sample Report of the Global Paracetamol Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: US Surgical Instrument Tracking System Market: US Surgical Instrument Tracking Market Size, Trends and Insights By Technology (Barcodes, RFID), By Application (Hardware, Software, Services), By End-use (Hospitals, Ambulatory Surgical Centers), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025-2034 Digital Mammography Market: Digital Mammography Market Size, Trends and Insights By Technology (2D Full Field Digital Mammography, 3D Full Field Digital Mammography (Digital Breast Tomosynthesis), Contrast Enhanced Digital Mammography), By Product Type (Digital Mammography System, Display Unit, Central Processing Units, Visualization Software), By End-user (Hospitals and Surgical Centers, Breast Care Centers, Diagnostic Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Lenacapavir Injection Market: Lenacapavir Injection Market Size, Trends and Insights By Indication (HIV Treatment, Pre-Exposure Prophylaxis (PrEP)), By Formulation (Injectable, Oral Tablets), By Distribution Channel (Branded Medicine, Generic Medicine), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Pharmaceutical Metal Detector Market: Pharmaceutical Metal Detector Market Size, Trends and Insights By Technology (Magnetic Field Detectors, Multi-frequency Detectors, X-Ray Inspection with Metal Detectors), By Application (Quality Control, Contaminant Detection, Packaging, Compliance), By End-user (Pharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Biopharmaceutical Companies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Deep Eutectic Solvents Market: Deep Eutectic Solvents Market Size, Trends and Insights By Product (Organic Salts + Metal Salts, Organic Salts + Metal Hydrates, Organic Salts + Hydrogen Bond Donor, Metal Chlorides + Hydrogen Bond Donor), By End-use (Pharmaceuticals & Healthcare, Food & Beverages Processing, Cosmetics & Personal Care, Chemical & Materials Industry), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025-2034 Medical Equipment Calibration Services Market: Medical Equipment Calibration Services Market Size, Trends and Insights By Service (In-house, Third-party Services, Original Equipment Manufacturers (OEMs)), By End-use (Hospitals, Clinical Laboratories), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 CRISPR and Cas Genes Market: CRISPR and Cas Genes Market Size, Trends and Insights By Technology Type (CRISPR/Cas9, CRISPR/Cas13, CRISPR/Cas14, Others), By Delivery Method (Ex vivo, In vivo, Physical Methods, Others), By Application Area (Functional Genomics, Oncology, Infectious Diseases, Others), By Tool Type (Guide RNA, CRISPR Plasmids, Cas Nucleases, Custom CRISPR Libraries, Vectors & Cloning Kits), By Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Industrial Crops), By Disease Type (Cancer, Blood Disorders, Ophthalmic Diseases, Infectious Diseases, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Y Chromosome Microdeletion Detection Kit Market: Y Chromosome Microdeletion Detection Kit Market Size, Trends and Insights By Product Type (PCR-based Kits, FISH-based Kits, Others), By Application (Hospitals, Diagnostic Laboratories, Research Institutes, Others), By End-User (Healthcare Providers, Research Laboratories, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 The Paracetamol Market is segmented as follows: By Product Type Tablet Capsule Liquid Suspension Powder By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Application Type Headache & Fever Muscle Cramps Cold & Cough Click Here to Get a Free Sample Report of the Global Paracetamol Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Paracetamol Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Global Key Players in This Paracetamol Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Global Market Status of the Paracetamol Market? What Was the Capacity, Production Value, Cost and PROFIT of the Paracetamol Market? What Is the Current Market Status of the Paracetamol Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Paracetamol Market by Considering Applications and Types? What Are Projections of the Global Paracetamol Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is Paracetamol Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Paracetamol Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Paracetamol Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Paracetamol Industry? Click Here to Access a Free Sample Report of the Global Paracetamol Market @ Reasons to Purchase Paracetamol Market Report Paracetamol Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Paracetamol Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Paracetamol Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Paracetamol Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Paracetamol market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium Paracetamol Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Paracetamol market analysis. The competitive environment of current and potential participants in the Paracetamol market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide Paracetamol market should find this report useful. The research will be useful to all market participants in the Paracetamol industry. Managers in the Paracetamol sector are interested in publishing up-to-date and projected data about the worldwide Paracetamol market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Paracetamol products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the Paracetamol Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Paracetamol Research Report | Fast Delivery Available - [220+ Pages] @ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Why Cincinnati Reds manager Terry Francona planned meeting if team had lost to Cubs
Why Cincinnati Reds manager Terry Francona planned meeting if team had lost to Cubs

Yahoo

time6 minutes ago

  • Yahoo

Why Cincinnati Reds manager Terry Francona planned meeting if team had lost to Cubs

CHICAGO – If Cincinnati Reds manager Terry Francona seemed as locked in as his players during this week's high-adversity series opener at Wrigley Field, maybe it's because he was. 'I was so into the whole game,' he said, 'because we wanted to win. And nobody felt sorry for themselves or for us. 'In fact, if we'd have lost, I probably would have talked to them.' Blindsided by an unplanned bullpen game for the second day in a row after their long, wet ordeal in the Bristol Motor Speedway sideshow game over the weekend, Reds reliever after Reds reliever kept the Chicago Cubs in check for a comeback, 3-2 win Monday night No need for a message after a finish like that. Besides, veteran Brent Suter did the inspirational honors well enough after the game anyway, Francona said. But had they lost another tough one after all that rain, extra travel and the sudden finger blister that waylaid their hottest starting pitcher in the second inning? 'That's what mean,' Francona said. 'We've had a lot thrown at us. And sometimes your margin for error's less. 'OK, then let's not make errors. Let's just play the game the way we know how.' 'This can be our time to shine. We don't have to feel sorry for ourselves.' The Reds went from the mess of Bristol, Tennessee, into the teeth of a final 50-game stretch run that opened with three against the Cubs and two of the next three series after that against two more of the NL's top teams: Philadelphia and Milwaukee. 'Divisional games are huge, especially where we are in the season,' said closer Emilio Pagán, who earned a career-high 24th save with a 1-2-3 ninth. 'And so we talked about it as we're not going to have any excuses moving forward.' That seems to especially apply to bullpen core that has carried a heavy load at times – none more than Scott Barlow, who has pitched in six of the Reds' last seven games, including two innings Monday. 'Everybody down there just wants the ball at all times,' Barlow said. 'We've just kind of had the attitude of, 'Bring it on.' ' This article originally appeared on Cincinnati Enquirer: Reds manager Terry Francona planned meeting if team had lost to Cubs

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store